Without the generous support of the following corporation, we would have had a much harder time getting anything done.

Bioneer

Corporation History

  Bioneer Corporation is the first Korean biotechnology company established in 1992. The company has developed state of art molecular biology products and technologies including oligonucleotides, thermostable polymerases, and instruments of gene manipulation (automatic nucleic acid extractor, thermal cycler, real-time QPCR instruments and DNA sequencer). From its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully-integrate its capability to develop next generation technologies in the post-genome era through the invention of new biochemistry and instruments. Bioneer now runs two production and research facilities in Korea which are a total of 226,000 square feet. Equipped with proprietary 384 synthesizers, these facilities contain a full production line for oligonucleotide and siRNA synthesis. In addition to DNA manufacturing, Bioneer processes recombinant proteins which are fermented and purified on proprietary purification systems.

  After a successful Initial Public Offering in December 2005, Bioneer Corp. launched Bioneer Inc., the wholly owned subsidiary. The American subsidiary is located in a 22,000 square foot production and distribution facility in Alameda, CA, the heart of the San Francisco Bay Area. The company is dedicated to providing state of art solutions to the global community of life science researchers in academia, biotech and pharmaceutical companies.

Bioneer’s Key Business Areas

Bioneer’s business areas are classified as follows:

 Molecular Biology Products

• DNA & RNA oligonucleotides
• AccuPower® nucleic acid amplification related kits
• AccuPrep® extraction & purification kits
• Enzymes, molecular weight markers and more

 Molecular Diagnostics

• AccuPower® Pathogen Diagnostics kits

 siRNA & Drug Discovery

• AccuTarget TM siRNA Genome-wide Libraries and siPEG Nanoparticles
• S. pombe Genome-wide Deletion Mutant Library (Drug target screening)

Bioneer Specialization

• Extensive IP portfolio – Bioneer’s intensive R&D has generated hundreds of patents and intellectual properties worldwide in both molecular biology and diagnostics.

• Large Scale Manufacturing Facilities – Bioneer has large manufacturing facilities including fermentation systems, chemical reactors and automated production lines. This infrastructure enables the production of hundreds of molecular biology and diagnostic products. Bioneer’s proprietary automatic manufacturing system provides superior quality and increases its economy-of-scale providing unique competitive advantages in cost and retail pricing.

• ISO 9001 / ISO13485 Certification – Bioneer products are manufactured under the strict quality control by ISO 9001 and ISO 13485 system guarantees the quality and reproducibility of the diagnostics products.